ClinConnect ClinConnect Logo
Search / Trial NCT05241925

Effects of Continuous and Interval Physical Training Through the Intensity of the Incremental Shuttle Walk Test, on Functional Capacity and Quality of Life in Women With Malignant Breast Cancer During Chemotherapy Treatment

Launched by UNIVERSITY OF NOVE DE JULHO · Feb 11, 2022

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Breast Cancer Exercise

ClinConnect Summary

This clinical trial is looking at how different types of physical exercise can help women with breast cancer who are undergoing chemotherapy. The study aims to understand how continuous exercise (like steady walking) and interval exercise (short bursts of intense activity) can improve physical ability and overall quality of life for these women. Since cancer treatment can lead to fatigue and other health issues, finding effective ways to exercise could be very beneficial.

To participate in this study, women need to have a confirmed diagnosis of breast cancer and be currently receiving chemotherapy. However, those with certain health conditions, like heart disease or severe breathing problems, will not be eligible. If you join the study, you can expect to engage in different types of exercise programs and help researchers learn more about how physical activity can support women during cancer treatment. Your participation could contribute to finding better ways to help others in similar situations.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • Diagnosis of confirmed breast cancer. Duration of adjuvant chemotherapy treatment. Undergoing surgery for breast cancer treatment.
  • Exclusion Criteria:
  • neoplasm prior to breast cancer
  • heart disease;
  • musculoskeletal disorder;
  • respiratory disease;
  • uncontrolled arterial hypertension - factors that limit the performance of any of the assessments and/or training in the study.
  • Not having undergone chemotherapy or radiotherapy prior to the diagnosis of breast cancer.

About University Of Nove De Julho

The University of Nove de Julho (UNINOVE) is a prestigious educational institution located in São Paulo, Brazil, renowned for its commitment to advancing research and innovation in the field of health sciences. As a clinical trial sponsor, UNINOVE aims to foster collaboration between academia and the healthcare industry, facilitating the development and evaluation of novel therapeutic interventions. With a robust infrastructure and a team of experienced researchers, the university is dedicated to conducting high-quality clinical trials that adhere to rigorous ethical standards and regulatory guidelines, ultimately contributing to improved health outcomes and the enhancement of medical knowledge.

Locations

Patients applied

0 patients applied

Trial Officials

Luciana Sampaio, PhD

Principal Investigator

University of Nove de Julho

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials